Nel Asa
BLOOD-BASED DIAGNOSIS THROUGH GENE EXPRESSION TECHNOLOGY
Export Market
Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
Additional Information
Finance
Total revenues:
6.301
Operating profit: -37.133
Operating profit before tax:
-32.719
Total assets: 1.457.625
Total equity:1.451.226
Currency: NOK (all numbers in thousands)
Management
Board Chairman:
Hanne K Skaarberg Holen
Board Members:
Hanne K Skaarberg Holen
Finn Marum Jebsen
Mogens Filtenborg
Ole Enger